Lupin launches Hydrocortisone Vale rate Cream

Lupin announced the launch of Hydrocortisone Vale rate Cream USP, 0.2%, having received an approval from the United States Food and Drug Administration (USFDA) earlier.

Lupin's Hydrocortisone Valerate Cream USP, 0.2%, is the generic equivalent of Westcort Cream, 0.2%, of Sun Pharmaceutical Industries Inc. It is indicated for the re lief of the Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients. Hydrocortisone Valerate Cream USP, 0.2%, (RLD: Westcort Cream) had an annual sales of approximately USD 11.5 million in the U.S. (IQVIA MAT September 2019).

Powered by Capital Market - Live News